본문 바로가기
KERD
논문KCI 등재

Relationships between Gut Microbiota and Autism Spectrum Disorders: Development and Treatment

Lisa Poupard|Guylène Page|Vincent Thoreau|Zahyra Kaouah
대한정신약물학회 (Korean College of Neuropsychopharmacology)|2024.11|Clinical Psychopharmacology and Neuroscience|제22권 제4호|pp. 554-564|DOI 10.9758/cpn.24.1179

3

조회

0

다운로드

0

인용

0

참고문헌

키워드

NeurodevelopmentGastrointestinal microbiomeAutism spectrum disordersFecal microbiota transplantation.

초록

Many studies have demonstrated the impact of intestinal microbiota on normal brain development. Moreover, the gut microbiota (GM) is impacted by multiple endogenous and environmental factors that may promote gut dysbiosis (GD). An increasing number of studies are investigating the possible role of the GD in the development of neurological and behavioral disorders. For autism spectrum disorders (ASD), specific intestinal bacterial signatures have been identified, knowing that gastrointestinal symptoms are frequently found in ASD. In this review, the peri and post-natal factors modulating the GM are described and the specific gut bacterial signature of ASD children is detailed. Through bidirectional communication between the GM and the brain, several mechanisms are involved in the development of ASD, such as cytokine-mediated neuroinflammation and decreased production of neuroprotective factors such as short-chain fatty acids by the GM. Imbalance of certain neurotransmitters such as serotonin or gamma-aminobutyric acid could also play a role in these gut-brain interactions. Some studies show that this GD in ASD is partly reversible by treatment with pre- and probiotics, or fecal microbiota transplantation with promising results. However, certain limitations have been raised, in particular concerning the short duration of treatment, the small sample sizes and the diversity of protocols. The development of standardized therapeutics acting on GD in large cohort could rescue the gastrointestinal symptoms and behavioral impairments, as well as patient management.

Abstract

Many studies have demonstrated the impact of intestinal microbiota on normal brain development. Moreover, the gut microbiota (GM) is impacted by multiple endogenous and environmental factors that may promote gut dysbiosis (GD). An increasing number of studies are investigating the possible role of the GD in the development of neurological and behavioral disorders. For autism spectrum disorders (ASD), specific intestinal bacterial signatures have been identified, knowing that gastrointestinal symptoms are frequently found in ASD. In this review, the peri and post-natal factors modulating the GM are described and the specific gut bacterial signature of ASD children is detailed. Through bidirectional communication between the GM and the brain, several mechanisms are involved in the development of ASD, such as cytokine-mediated neuroinflammation and decreased production of neuroprotective factors such as short-chain fatty acids by the GM. Imbalance of certain neurotransmitters such as serotonin or gamma-aminobutyric acid could also play a role in these gut-brain interactions. Some studies show that this GD in ASD is partly reversible by treatment with pre- and probiotics, or fecal microbiota transplantation with promising results. However, certain limitations have been raised, in particular concerning the short duration of treatment, the small sample sizes and the diversity of protocols. The development of standardized therapeutics acting on GD in large cohort could rescue the gastrointestinal symptoms and behavioral impairments, as well as patient management.

참고문헌 (79)

  1. "Diagnostic Criteria | Autism Spectrum Disorder (ASD) | NCBDDD | CDC" (2023)[URL]
  2. Iles A, "Autism spectrum disorders", Prim Care, 48, pp.461~473 (2021)
  3. Wang L, "Autism spectrum disorder : neurodevelopmental risk factors, biological mecha-nism, and precision therapy", Int J Mol Sci, 24, pp.1819~ (2023)
  4. Salari N, "The global prevalence of autism spectrum disorder : a comprehensive systematic review and meta-analysis", Ital J Pediatr, 48, pp.112~ (2022)
  5. Lord C, "Autism spectrum disorder", Lancet, 392, pp.508~520 (2018)
  6. Fattorusso A, "Autism spectrum disorders and the gut microbiota", Nutrients, 11, pp.521~ (2019)
  7. Góralczyk-Bińkowska A, "The microbiota-gut-brain axis in psychiatric disorders", Int J Mol Sci, 23, pp.11245~ (2022)
  8. Leader G, "Gastrointestinal symptoms in autism spectrum disorder : a systematic review", Nutrients, 14, pp.1471~ (2022)
  9. Adams JB, "Gastrointestinal flora and gastrointestinal status in children with autism--comparisons to typical children and correlation with autism severity", BMC Gastroenterol, 11, pp.22~ (2011)
  10. Reynolds AM, "Gastrointestinal symptoms in 2-to 5-year-old children in the study to explore early development", J Autism Dev Disord, 51, pp.3806~3817 (2021)
  11. Madra M, "Gastrointestinal issues and autism spectrum disorder", Psychiatr Clin North Am, 44, pp.69~81 (2021)
  12. Socała K, "The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders", Pharmacol Res, 172, pp.105840~ (2021)
  13. Iglesias-Vázquez L, "Composition of gut microbiota in children with autism spectrum disorder : a systematic review and meta-analysis", Nutrients, 12, pp.792~ (2020)
  14. Chernikova MA, "The brain-gut-microbiome system : pathways and implications for autism spectrum disorder", Nutrients, 13, pp.4497~ (2021)
  15. Wong GC, "Autism spectrum disorders" (2021), Exon Publications
  16. Vuong HE, "The maternal microbiome modulates fetal neurodevelopment in mice", Nature, 586, pp.281~286 (2020)
  17. Lu J, "Microbiota influence the development of the brain and behaviors in C57BL", 6J mice, 2018, pp.13, e0201829~
  19. Benagiano M, "Long-term consequences of placental vascular pathology on the maternal and offspring cardiovascular systems", Biomolecules, 11, pp.1625~ (2021)
  20. Choi GB, "The maternal interleukin-17a pathway in mice promotes autismlike phenotypes in offspring", Science, 351, pp.933~939 (2016)
  21. Shin Yim Y, "Reversing behavioural abnormalities in mice exposed to maternal inflammation", Nature, 549, pp.482~487 (2017)
  22. Stoner R, "Patches of disorganization in the neocortex of children with autism", N Engl J Med, 370, pp.1209~1219 (2014)
  23. Sharon G, "The central nervous system and the gut microbiome", Cell, 167, pp.915~932 (2016)
  24. Xiao L, "Fecal microbiome transplantation from children with autism spectrum disorder modulates tryptophan and serotonergic synapse metabolism and induces altered behaviors in germ-free mice", mSystems, 6, pp.e01343-e01320~ (2021)
  25. Evrensel A, "Fecal microbiota transplantation and its usage in neuropsychiatric disorders", Clin Psychopharmacol Neurosci, 14, pp.231~237 (2016)
  26. Alharthi A, "The human gut microbiome as a potential factor in autism spectrum disorder", Int J Mol Sci, 23, pp.1363~ (2022)
  27. Park SH, "Cognitive function improvement after fecal microbiota transplantation in Alzheimer’s dementia patient : a case report", Curr Med Res Opin, 37, pp.1739~1744 (2021)
  28. Park SH, "Fecal microbiota transplantation can improve cognition in patients with cognitive decline and Clostridioides difficile infection", Aging(Albany NY), 14, pp.6449~6466 (2022)
  29. Li N, "Fecal microbiota transplantation relieves gastrointestinal and autism symptoms by improving the gut microbiota in an open-label study", Front Cell Infect Microbiol, 11, pp.759435~ (2021)
  30. Willyard C, "How gut microbes could drive brain disorders", Nature, 590, pp.22~25 (2021)
  31. Younge N, "Fetal exposure to the maternal microbiota in humans and mice", JCI Insight, 4, pp.e127806~ (2019)
  32. González S, "Levels of predominant intestinal microorganisms in 1 month-old full-term babies and weight gain during the first year of life", Nutrients, 13, pp.2412~ (2021)
  33. Raspini B, "Prenatal and postnatal determinants in shaping offspring’s microbiome in the first 1000 days : study protocol and preliminary results at one month of life", Ital J Pediatr, 46, pp.45~ (2020)
  34. Bokulich NA, "Antibiotics, birth mode, and diet shape microbiome maturation during early life", Sci Transl Med, 8, pp.343~ (2016)
  35. McDonnell L, "Association between antibiotics and gut microbiome dysbiosis in children : systematic review and meta-analysis", Gut Microbes, 13, pp.1~18 (2021)
  36. Korpela K, "Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children", Nat Commun, 7, pp.10410~ (2016)
  37. Galley JD, "Exposure to a social stressor disrupts the community structure of the colonic mucosa-associated microbiota", BMC Microbiol, 14, pp.189~ (2014)
  38. Coretti L, "Gut microbiota features in young children with autism spectrum disorders", Front Microbiol, 9, pp.3146~ (2018)
  39. Wang H, "Gut microbiota signature in children with autism spectrum disorder who suffered from chronic gastrointestinal symptoms", BMC Pediatr, 23, pp.476~ (2023)
  40. Morton JT, "Multi-level analysis of the gut-brain axis shows autism spectrum disorder-associated molecular and microbial profiles", Nat Neurosci, 26, pp.1208~1217 (2023)
  41. Zuffa S, "Early-life differences in the gut microbiota composition and functionality of infants at elevated likelihood of developing autism spectrum disorder", Transl Psychiatry, 13, pp.257~ (2023)
  42. Jendraszak M, "Commercial microbiota test revealed differences in the composition of intestinal microorganisms between children with autism spectrum disorders and neurotypical peers", Sci Rep, 11, pp.24274~ (2021)
  43. Magalhães-Guedes KT, "Psychobiotic therapy : method to reinforce the immune system", Clin Psychopharmacol Neurosci, 20, pp.17~25 (2022)
  44. Zhu S, "The progress of gut microbiome research related to brain disorders", J Neuroinflammation, 17, pp.25~ (2020)
  45. Dash S, "Understanding the role of the gut microbiome in brain development and its association with neurodevelopmental psychiatric disorders", Front Cell Dev Biol, 10, pp.880544~ (2022)
  46. Bojović K, "Gut microbiota dysbiosis associated with altered production of short chain fatty acids in children with neurodevelopmental disorders", Front Cell Infect Microbiol, 10, pp.223~ (2020)
  47. Silva YP, "The role of short-chain fatty acids from gut microbiota in gut-brain communication", Front Endocrinol(Lausanne), 11, pp.25~ (2020)
  48. Saurman V, "Autism spectrum disorder as a brain-gut-microbiome axis disorder", Dig Dis Sci, 65, pp.818~828 (2020)
  49. Yang LL, "Enteric short-chain fatty acids promote proliferation of human neural progenitor cells", J Neurochem, 154, pp.635~646 (2020)
  50. Madore C, "Neuroinflammation in autism : plausible role of maternal inflammation, dietary omega 3, and microbiota", Neural Plast, 2016, pp.3597209~ (2016)
  51. Downs R, "Model-based hypothesis of gut microbe populations and gut", brain barrier permeabilities in the development of regressive autism, 2014, pp.83, 649~655
  52. Reed MD, "IL-17a promotes sociability in mouse models of neurodevelopmental disorders", Nature, 577, pp.249~253 (2020)
  53. Tran SM, "The role of gut bacterial metabolites in brain development, aging and disease", Nutrients, 13, pp.732~ (2021)
  54. Jenkins TA, "Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis", Nutrients, 8, pp.56~ (2016)
  55. Raghavan R, "Association between cord blood metabolites in tryptophan pathway and childhood risk of autism spectrum disorder and attention-deficit hyperactivity disorder", Transl Psychiatry, 12, pp.270~ (2022)
  56. Duranti S, "Bifidobacterium adolescentis as a key member of the human gut microbiota in the production of GABA", Sci Rep, 10, pp.14112~ (2020)
  57. Marotta R, "The neurochemistry of autism", Brain Sci, 10, pp.163~ (2020)
  58. Kolodny T, "Concentrations of cortical GABA and glutamate in young adults with autism spectrum disorder", Autism Res, 13, pp.1111~1129 (2020)
  59. Gaetz W, "GABA estimation in the brains of children on the autism spectrum : measurement precision and regional cortical variation", Neuroimage, 86, pp.1~9 (2014)
  60. Makris G, "Stress system activation in children and adolescents with autism spectrum disorder", Front Neurosci, 15, pp.756628~ (2022)
  61. Liu J, "Alteration of gut microbiota : new strategy for treating autism spectrum disorder", Front Cell Dev Biol, 10, pp.792490~ (2022)
  62. Grimaldi R, "A prebiotic intervention study in children with autism spectrum disorders(ASDs)", Microbiome, 6, pp.133~ (2018)
  63. Chang JP, "Nutritional neuroscience as mainstream of psychiatry : the evidence-based treatment guidelines for using omega-3 fatty acids as a new treatment for psychiatric disorders in children and adolescents", Clin Psychopharmacol Neurosci, 18, pp.469~483 (2020)
  64. Mazahery H, "Relationship between long chain n-3 polyunsaturated fatty acids and autism spectrum disorder : systematic review and meta-analysis of case-control and randomised controlled trials", Nutrients, 9, pp.155~ (2017)
  65. Kong XJ, "Probiotic and oxytocin combination therapy in patients with autism spectrum disorder : a randomized, double-blinded, placebo-controlled pilot trial", Nutrients, 13, pp.1552~ (2021)
  66. Amadi CN, "Dietary interventions for autism spectrum disorder : an updated systematic review of human studies", Psychiatriki, 33, pp.228~242 (2022)
  67. Arnold LE, "Probiotics for gastrointestinal symptoms and quality of life in autism : a placebo-controlled pilot trial", J Child Adolesc Psychopharmacol, 29, pp.659~669 (2019)
  68. Sanctuary MR, "Pilot study of probiotic", colostrum supplementation on gut function in children with autism and gastrointestinal symptoms, 2019, pp.14, e0210064~
  69. He X, "Effects of probiotics on autism spectrum disorder in children : a systematic review and meta-analysis of clinical trials", Nutrients, 15, pp.1415~ (2023)
  70. Ng QX, "A systematic review of the role of prebiotics and probiotics in autism spectrum disorders", Medicina(Kaunas), 55, pp.129~ (2019)
  71. Feng P, "A review of probiotics in the treatment of autism spectrum disorders : perspectives from the gut-brain axis", Front Microbiol, 14, pp.1123462~ (2023)
  72. Needham BD, "Searching for the gut microbial contributing factors to social behavior in rodent models of autism spectrum disorder", Dev Neurobiol, 78, pp.474~499 (2018)
  73. Kang DW, "Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms : an open-label study", Microbiome, 5, pp.10~ (2017)
  74. Kang DW, "Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota", Sci Rep, 9, pp.5821~ (2019)
  75. Zhao H, "Mo1667 fecal microbiota transplantation for children with autism spectrum disorder", Gastrointest Endosc, 89(6 Suppl), pp.AB512~AB513 (2019)
  76. Hu C, "Fecal microbiota transplantation in a child with severe ASD comorbidities of gastrointestinal dysfunctions-a case report", Front Psychiatry, 14, pp.1219104~ (2023)
  77. Zhang Y, "Effects of washed fecal bacteria transplantation in sleep quality, stool features and autism symptomatology : a Chinese preliminary observational study", Neuropsychiatr Dis Treat, 18, pp.1165~1173 (2022)
  78. Chen Y, "FTACMT study protocol : a multicentre, double-blind, randomised, placebo-controlled trial of faecal microbiota transplantation for autism spectrum disorder", BMJ Open, 12, pp.e051613~ (2022)
  79. Wei J, "Protocol for the safety and efficacy of fecal microbiota transplantation liquid in children with autism spectrum disorder : a randomized controlled study", Front Microbiol, 14, pp.1236904~ (2023)

관련 논문AI추천

A Meta-analysis of Randomized Placebo-controlled Trials on the Effects of Probiotics for Autism Spectrum DisordersCheuk-Kwan Sun, Kuo-Chuan Hung, Ping-Wen Huang, Shun-Chin Liang, Yu-Shian Cheng대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2025 · 제23권 제4호The Gut-Brain Axis: The Missing Link in DepressionAlper Evrensel, Mehmet Emin Ceylan대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2015 · 제13권 제3호발달장애와 장내미생물 : 운동 및 식이 중재 중심으로오탁진, 홍광석학교체육연구소 · Asian Journal of Physical Education and Sport Science2025 · 제13권 제3호Maladaptive Behavior and Gastrointestinal Disorders in Children with Autism Spectrum DisorderAgus Firmansyah, Hardiono D. Pusponegoro, Sofyan Ismael, Sudigdo Sastroasmoro, Yvan Vandenplas대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2015 · 제18권 제4호Regulation of common neurological disorders by gut microbial metabolitesKim Chang H., Park Jeongho생화학분자생물학회 · Experimental and Molecular Medicine2021 · 제53권 Microglia and Autism Spectrum Disorder: Overview of Current Evidence and Novel Immunomodulatory Treatment OptionsJi Yeon Hong, Jung Won Kim, Seung Min Bae대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2018 · 제16권 제3호

이 간행물의 다른 논문 (15건)

Remembering Chae Won Kim, Pioneer of Psychopharmacology in KoreaSuk Kyoon An, Chan-Hyung Kim, Junghan Lee, Young Hyeong Seol, In-Sok Yeopp. 551-553Psychosomatics: Communication of the Central Nervous System through Connection to Tissues, Organs, and CellsAndrei Efremovpp. 565-577Ultradian Rest-activity Rhythms Induced by Quinpirole in Mice Using Wavelet AnalysisEunsoo Moon, Yoo Rha Hong, Jung Hyun Lee, Kyungwon Kim, Jeonghyun Park, Min Yoon, Hwagyu Suh, Hyun Ju Limpp. 578-584Relationship between Polygenic Risk Score and the Hypnotics in Bipolar I DisorderTatyana Shekhtman, Young-Min Park, Hyeon Woo Lee, Bun-Hee Lee, John R. Kelsoepp. 585-593Feasibility of Using Serum, Plasma, and Platelet 5-hydroxytryptamine as Peripheral Biomarker for the Depression Diagnosis and Response Evaluation to Antidepressants: Animal Experimental StudyFeng Xu, Zhijun Xiao, Yuanchi Cheng, Ting Zhou, Jingjing Duan, Canye Li, Jinming Cao, Zhicong Chen, Zuanjun Su, Zhen Yangpp. 594-609
원문 보기